The first identified soluble ligand of PTPRZ was pleiotrophin (PTN), a secreted heparin-binding growth factor highly expressed in the embryonic nervous system and other embryonic organs, and overexpressed in several cancer cell lines [259]. Here, PTN is linked to cancer.